Abdel Saidmeerasah

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIMS To investigate the effect of the different eligibility criteria used by phase III clinical studies in heart failure with preserved ejection fraction (HFpEF) on patient selection, phenotype, and survival. METHODS AND RESULTS We applied the key eligibility criteria of 7 phase III HFpEF studies (Digitalis Investigation Group Ancillary, Candesartan in(More)
  • 1